Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Clot-Busting Stroke Drug Could Save $200M Annually

Treating mild strokes with an intravenous tissue plasminogen activator (tPA), a drug usually reserved for more severe strokes, could save costs by reducing the disabling after-effects of a stroke, researchers say.

Please enter your comment below:
Please enter the text below: